• 
• 
• 
• 
• 
• 

Press releases

• 5/11/2012
  Biofrontera publishes interim report for the 1st Quarter of 2012

• 5/3/2012
  Ad-hoc: Biofrontera AG redeems 8 % convertible bond of 2005/2012

• 5/2/2012
  Ad-hoc: Biofrontera AG lists New Shares at the regulated stock market

• 4/4/2012
  Biofrontera and Bipharma sign exclusive marketing and distribution agreement for Ameluz® for the Benelux

• 4/4/2012
  Ad-hoc: Biofrontera AG: Distribution Agreement with Bipharma for Ameluz® in the Benelux

• 3/30/2012
  Biofrontera publishes financial report 2011

• 3/29/2012
  Ad-hoc: Distribution Agreement with Allergan for Ameluz® in Spain

• 3/29/2012
  Distribution Agreement with Allergan in Spain

• 3/23/2012
  Ad-hoc: Biofrontera AG: 4,402,682 shares subscribed in capital increase

• 3/2/2012
  Ad-hoc: Biofrontera AG decides on capital increase

• 2/29/2012
  Ad-hoc: Distribution Agreement with Allergan for Ameluz® in Spain

• 2/6/2012
  Biofrontera and Desitin sign marketing and distribution agreement for Ameluz® in Scandinavia

• 2/6/2012
  Ad-hoc: Biofrontera AG: Distribution Agreement with Desitin for Ameluz® in Scandinavia

• 2/3/2012
  Ad-hoc: Biofrontera AG – 500,000 shares subscribed in capital increase

• 2/1/2012
  Biofrontera‘s Ameluz® as of today available in all German pharmacies